Microport Cardioflow Medtech Corp
HKEX:2160

Watchlist Manager
Microport Cardioflow Medtech Corp Logo
Microport Cardioflow Medtech Corp
HKEX:2160
Watchlist
Price: 0.82 HKD 3.8% Market Closed
Market Cap: 2B HKD

Microport Cardioflow Medtech Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Microport Cardioflow Medtech Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Microport Cardioflow Medtech Corp
HKEX:2160
Revenue
ÂĄ361.6m
CAGR 3-Years
22%
CAGR 5-Years
76%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Revenue
ÂĄ1.7B
CAGR 3-Years
51%
CAGR 5-Years
47%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Revenue
ÂĄ7.3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
16%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Revenue
ÂĄ37.1B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Revenue
ÂĄ6.5B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
15%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Revenue
ÂĄ11.4B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Microport Cardioflow Medtech Corp
Glance View

Market Cap
2B HKD
Industry
Health Care

MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

Intrinsic Value
1.83 HKD
Undervaluation 55%
Intrinsic Value
Price

See Also

What is Microport Cardioflow Medtech Corp's Revenue?
Revenue
361.6m CNY

Based on the financial report for Dec 31, 2024, Microport Cardioflow Medtech Corp's Revenue amounts to 361.6m CNY.

What is Microport Cardioflow Medtech Corp's Revenue growth rate?
Revenue CAGR 5Y
76%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Microport Cardioflow Medtech Corp have been 22% over the past three years , 76% over the past five years .

Back to Top